Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Price : 124.03 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 125.22 | 127.20 | 124.82 | 125.77 | 1.124M |
| Aug 20, 2026 | 128.36 | 130.27 | 124.60 | 125.08 | 1.762M |
| Aug 19, 2026 | 129.85 | 131.10 | 127.42 | 130.66 | 1.494M |
| Aug 18, 2026 | 128.07 | 128.93 | 126.39 | 128.46 | 1.274M |
| Aug 17, 2026 | 124.71 | 128.46 | 124.70 | 128.32 | 1.900M |
| Aug 14, 2026 | 125.67 | 126.84 | 122.21 | 123.74 | 1.957M |
| Aug 13, 2026 | 132.50 | 133.16 | 126.13 | 126.33 | 2.480M |
| Aug 12, 2026 | 132.31 | 135.26 | 130.80 | 132.28 | 1.563M |
| Aug 11, 2026 | 134.55 | 135.30 | 131.67 | 132.57 | 2.729M |
| Aug 10, 2026 | 129.98 | 135.50 | 129.50 | 134.75 | 3.630M |
| Aug 07, 2026 | 134.99 | 135.48 | 126.44 | 131.10 | 4.905M |
| Aug 06, 2026 | 128.22 | 137.70 | 126.15 | 132.55 | 12.04M |
| Aug 05, 2026 | 99.16 | 100.95 | 98.64 | 99.02 | 4.900M |
| Aug 04, 2026 | 98.98 | 99.48 | 97.86 | 98.75 | 4.291M |
| Aug 03, 2026 | 98.20 | 100.00 | 96.42 | 98.45 | 3.547M |
| Jul 31, 2026 | 101.25 | 101.91 | 97.05 | 98.60 | 2.903M |
| Jul 30, 2026 | 101.63 | 102.10 | 99.03 | 101.49 | 3.363M |
| Jul 29, 2026 | 103.98 | 106.26 | 102.81 | 103.12 | 2.196M |
| Jul 28, 2026 | 104.73 | 105.76 | 103.18 | 104.13 | 1.946M |
| Jul 27, 2026 | 106.93 | 107.37 | 104.50 | 104.73 | 1.900M |
| Jul 24, 2026 | 106.49 | 108.27 | 105.77 | 106.92 | 1.908M |
| Jul 23, 2026 | 105.80 | 107.88 | 105.09 | 107.41 | 1.753M |
| Jul 22, 2026 | 109.47 | 109.99 | 106.12 | 106.64 | 1.771M |
| Jul 21, 2026 | 107.87 | 109.42 | 106.41 | 108.62 | 2.447M |
| Jul 20, 2026 | 108.24 | 109.80 | 106.63 | 107.02 | 2.016M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 236.06 |
| United Therapeutics Corp. | 513.04 |
| ACADIA Pharmaceuticals, Inc. | 29.63 |
| Biogen, Inc. | 218.11 |
| Gilead Sciences, Inc. | 146.76 |
Price Related Metrics
| PS Ratio | 23.39 |
| Price to Book Value | 35.74 |
| Earnings Yield | -3.31% |
| Market Cap | 27.07B |